Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Netherlands first to approve Vesomni

May 23, 2013

Dosing completed in phase I TTI-1612 study

May 17, 2013

Mirabegron/solifenacin as an effective therapeutic option for overactive bladder

May 16, 2013

Fedovapagon effectively reduces nocturia in men with BPH

May 15, 2013

Relypsa completes enrollment in pivotal phase III trial of patiromer

May 14, 2013

Astellas and Drais form new partnership to develop treatment candidate for nocturia

May 8, 2013

Roche patents new CYP11B2 inhibitors

April 22, 2013

Nymox's candidate for BPH shows promising sexual function profile in new study

April 18, 2013

Innovative 3D renal tissue model developed to investigate human disease and toxicity

April 18, 2013

FDA sets PDUFA action date for PA-21

April 16, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...